Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
1 trials
Recent
Start date
Enrollment
INDUSTRY
×
Monoclonal Gammopathy of Undetermined Significance
×
90 days
×
Clear all
Filters
3
NCT06140524
2026-01-22
LINKER-MGUS1
Regeneron Pharmaceuticals
Phase 2
Recruiting
116 enrolled